Mallinckrodt Pharmaceuticals

Nov 14, 2017

Mallinckrodt To Present At The BMO Prescriptions for Success Healthcare Conference

Oct 18, 2017

Mallinckrodt To Present At The Stifel 2017 Healthcare Conference

Oct 16, 2017

Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students

Sep 20, 2017

Mallinckrodt Announces Election Of David Norton To Its Board Of Directors

Aug 15, 2017

Mallinckrodt To Present At Morgan Stanley 15th Annual Global Healthcare Conference

Aug 07, 2017

Mallinckrodt To Present At Wells Fargo Securities 2017 Healthcare Conference

Aug 01, 2017

Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates

Jul 18, 2017

U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy

Jul 05, 2017

Mallinckrodt Announces Specialty Brands Investor Briefing

Jun 23, 2017

Health Economic Data on Burden of Hepatorenal Syndrome Published in Current Medical Research and Opinion

Jun 21, 2017

Mallinckrodt and Massachusetts Health & Hospital Association Announce Joint Initiative for Developing Pain Stewardship Programs Within Hospitals